Elo Mutual Pension Insurance Co Sells 4,569 Shares of CVS Health Co. (NYSE:CVS)

Elo Mutual Pension Insurance Co lowered its holdings in shares of CVS Health Co. (NYSE:CVS) by 3.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 114,801 shares of the pharmacy operator’s stock after selling 4,569 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in CVS Health were worth $5,153,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in CVS. Larson Financial Group LLC grew its position in shares of CVS Health by 258.9% during the 3rd quarter. Larson Financial Group LLC now owns 3,542 shares of the pharmacy operator’s stock valued at $223,000 after acquiring an additional 2,555 shares during the period. The Manufacturers Life Insurance Company grew its holdings in CVS Health by 7.8% during the third quarter. The Manufacturers Life Insurance Company now owns 1,096,238 shares of the pharmacy operator’s stock valued at $68,931,000 after purchasing an additional 79,132 shares during the period. Avestar Capital LLC purchased a new stake in CVS Health in the third quarter worth about $326,000. RPg Family Wealth Advisory LLC purchased a new position in shares of CVS Health during the 3rd quarter valued at about $40,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of CVS Health by 3.7% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 261,194 shares of the pharmacy operator’s stock valued at $16,424,000 after acquiring an additional 9,418 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS stock opened at $67.59 on Friday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The firm has a market capitalization of $85.22 billion, a P/E ratio of 18.47, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The company has a fifty day simple moving average of $61.83 and a two-hundred day simple moving average of $57.60. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.94%. The ex-dividend date is Tuesday, April 22nd. CVS Health’s dividend payout ratio is currently 72.68%.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent analyst reports. Piper Sandler raised their target price on shares of CVS Health from $72.00 to $74.00 and gave the stock an “overweight” rating in a research note on Friday, March 21st. StockNews.com upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 13th. UBS Group dropped their target price on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a report on Tuesday, February 11th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Finally, Barclays increased their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $70.39.

Insider Activity at CVS Health

In other CVS Health news, Director Michael F. Mahoney acquired 30,000 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now directly owns 39,356 shares of the company’s stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.